Market Overview:
The global IVD infectious disease market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for rapid and accurate diagnosis, and technological advancements in the field of IVD diagnostics. The global IVD infectious disease market is segmented on the basis of type into biochemical diagnosis, immune diagnosis, molecular diagnosis, microbiological diagnosis, urine diagnostic and coagulation diagnostic. On the basis of application, the market is segmented into personal use (point-of-care testing), commercial use (laboratories), academic research institutions and other applications (government institutes). Geographically, the global IVD infectious disease market is segmented into North America, Latin America Europe Asia Pacific and Middle East & Africa.
Product Definition:
IVD Infectious Disease is a type of disease that is caused by the invasion of pathogens into the body. This can lead to a wide range of symptoms, and in some cases can be deadly. The importance of IVD Infectious Disease can not be overstated, as it is responsible for millions of deaths every year worldwide.
Biochemical Diagnosis:
The global biochemical diagnosis market size was valued at USD 4.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The growth of this industry can be attributed to factors such as rising prevalence of target diseases, increasing demand for point-of-care testing (POCT), and growing R&D activities by key players in the field of infectious disease diagnostics and therapeutics such as Gilead Sciences, Inc.
Immune Diagnosis:
Immune diagnosis is a technique used to detect the presence of an immune response to a particular antigen in patients suffering from infectious diseases. The most common method used for immune diagnosis is blood tests or skin test. These tests are conducted either on fresh samples or sample frozen at the time of testing and can be done using various instruments such as ELISA (enzyme-linked immunosorbent assay), RIA (radioimmunoassay), flow cytometry, and other laboratory equipment.
Application Insights:
The academic segment held the largest share of over 70.0% in 2017. The growth can be attributed to factors such as an increase in research activities pertaining to infectious diseases and increasing investments by governments for the development of diagnostic centers and laboratories. For instance, according to a study published in 2016 by WHO, around 10 million people die each year due to infections that are treatable with effective vaccines. Furthermore, many emerging economies are investing significantly for the development of diagnostics & therapeutics products for major infectious diseases which is expected to drive market growth during the forecast period (2017-2030).
The personal segment is anticipated register a lucrative CAGR during the forecast period owing to factors such as growing awareness about preventable diseases among individuals at risk groups including healthcare professionals and family members who have not been immunized against these diseases or have not received any doses so far.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of players, high adoption rate for advanced technologies, and favorable government initiatives are some factors attributing to the largest share. For instance, in February 2016, CDC launched COVID-19–Saving Lives: A New Vision and Mission Strategy to prevent and control infectious disease by 2025. This initiative aims at accelerating progress against important infectious disease challenges including chronic diseases as well as biothreats.
Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to increasing awareness about various tests & their benefits coupled with growing disposable income & healthcare expenditure levels among people living in this region. Moreover, rising cases of chronic diseases due to unhealthy lifestyles will boost demand for testing services over the forecast period; hence driving growth across this region as well – particularly India & China (APAC).
Growth Factors:
- Increasing incidence of infectious diseases: The incidence of infectious diseases is increasing at a rapid pace across the globe. This is primarily owing to the changing lifestyle and environmental conditions. This, in turn, is propelling the demand for IVD products for diagnosis and treatment of these infections.
- Rising awareness about preventive measures: There has been a rise in awareness among people about preventive measures against infectious diseases in recent years. This is aiding the growth of the IVD Infectious Disease market as more people are opting for early diagnosis and treatment of infections through use of diagnostic tests and therapies.
- Technological advancements: The development of novel technologies such as next-generation sequencing (NGS) has revolutionized diagnostics for infectious diseases, making it easier and faster to detect pathogens causing these infections accurately. This is resulting in increased adoption rates of diagnostic tests by healthcare professionals, thereby driving market growth further..
Scope Of The Report
Report Attributes
Report Details
Report Title
IVD Infectious Disease Market Research Report
By Type
Biochemical Diagnosis, Immune Diagnosis, Molecular Diagnosis, Microbiological Diagnosis, Urine Diagnosis, Coagulation Diagnosis, Other
By Application
Personal, Commercial, Academic, Other
By Companies
Roche Diagnostics, Abbott Laboratories, Abbott, Gen-Probe, Becton Dickinson (BD), Bio-Rad Laboratories, Siemens Healthcare, Biomérieux, Danaher, Thermo Fisher, Sysmex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global IVD Infectious Disease Market Report Segments:
The global IVD Infectious Disease market is segmented on the basis of:
Types
Biochemical Diagnosis, Immune Diagnosis, Molecular Diagnosis, Microbiological Diagnosis, Urine Diagnosis, Coagulation Diagnosis, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Personal, Commercial, Academic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abbott Laboratories
- Abbott
- Gen-Probe
- Becton Dickinson (BD)
- Bio-Rad Laboratories
- Siemens Healthcare
- Biomérieux
- Danaher
- Thermo Fisher
- Sysmex
Highlights of The IVD Infectious Disease Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biochemical Diagnosis
- Immune Diagnosis
- Molecular Diagnosis
- Microbiological Diagnosis
- Urine Diagnosis
- Coagulation Diagnosis
- Other
- By Application:
- Personal
- Commercial
- Academic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the IVD Infectious Disease Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IVD is short for infectious disease. IVD refers to any infection that can be spread from person to person, including viruses, bacteria, and parasites. IVDs can cause serious health problems if not treated properly.
Some of the major companies in the ivd infectious disease market are Roche Diagnostics, Abbott Laboratories, Abbott, Gen-Probe, Becton Dickinson (BD), Bio-Rad Laboratories, Siemens Healthcare, BiomƒÂ©rieux, Danaher, Thermo Fisher, Sysmex.
The ivd infectious disease market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 IVD Infectious Disease Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 IVD Infectious Disease Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 IVD Infectious Disease Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the IVD Infectious Disease Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global IVD Infectious Disease Market Size & Forecast, 2018-2028 4.5.1 IVD Infectious Disease Market Size and Y-o-Y Growth 4.5.2 IVD Infectious Disease Market Absolute $ Opportunity
Chapter 5 Global IVD Infectious Disease Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 IVD Infectious Disease Market Size Forecast by Type
5.2.1 Biochemical Diagnosis
5.2.2 Immune Diagnosis
5.2.3 Molecular Diagnosis
5.2.4 Microbiological Diagnosis
5.2.5 Urine Diagnosis
5.2.6 Coagulation Diagnosis
5.2.7 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global IVD Infectious Disease Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 IVD Infectious Disease Market Size Forecast by Applications
6.2.1 Personal
6.2.2 Commercial
6.2.3 Academic
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global IVD Infectious Disease Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 IVD Infectious Disease Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America IVD Infectious Disease Analysis and Forecast
9.1 Introduction
9.2 North America IVD Infectious Disease Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America IVD Infectious Disease Market Size Forecast by Type
9.6.1 Biochemical Diagnosis
9.6.2 Immune Diagnosis
9.6.3 Molecular Diagnosis
9.6.4 Microbiological Diagnosis
9.6.5 Urine Diagnosis
9.6.6 Coagulation Diagnosis
9.6.7 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America IVD Infectious Disease Market Size Forecast by Applications
9.10.1 Personal
9.10.2 Commercial
9.10.3 Academic
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe IVD Infectious Disease Analysis and Forecast
10.1 Introduction
10.2 Europe IVD Infectious Disease Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe IVD Infectious Disease Market Size Forecast by Type
10.6.1 Biochemical Diagnosis
10.6.2 Immune Diagnosis
10.6.3 Molecular Diagnosis
10.6.4 Microbiological Diagnosis
10.6.5 Urine Diagnosis
10.6.6 Coagulation Diagnosis
10.6.7 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe IVD Infectious Disease Market Size Forecast by Applications
10.10.1 Personal
10.10.2 Commercial
10.10.3 Academic
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific IVD Infectious Disease Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific IVD Infectious Disease Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific IVD Infectious Disease Market Size Forecast by Type
11.6.1 Biochemical Diagnosis
11.6.2 Immune Diagnosis
11.6.3 Molecular Diagnosis
11.6.4 Microbiological Diagnosis
11.6.5 Urine Diagnosis
11.6.6 Coagulation Diagnosis
11.6.7 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific IVD Infectious Disease Market Size Forecast by Applications
11.10.1 Personal
11.10.2 Commercial
11.10.3 Academic
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America IVD Infectious Disease Analysis and Forecast
12.1 Introduction
12.2 Latin America IVD Infectious Disease Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America IVD Infectious Disease Market Size Forecast by Type
12.6.1 Biochemical Diagnosis
12.6.2 Immune Diagnosis
12.6.3 Molecular Diagnosis
12.6.4 Microbiological Diagnosis
12.6.5 Urine Diagnosis
12.6.6 Coagulation Diagnosis
12.6.7 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America IVD Infectious Disease Market Size Forecast by Applications
12.10.1 Personal
12.10.2 Commercial
12.10.3 Academic
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) IVD Infectious Disease Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) IVD Infectious Disease Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) IVD Infectious Disease Market Size Forecast by Type
13.6.1 Biochemical Diagnosis
13.6.2 Immune Diagnosis
13.6.3 Molecular Diagnosis
13.6.4 Microbiological Diagnosis
13.6.5 Urine Diagnosis
13.6.6 Coagulation Diagnosis
13.6.7 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) IVD Infectious Disease Market Size Forecast by Applications
13.10.1 Personal
13.10.2 Commercial
13.10.3 Academic
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 IVD Infectious Disease Market: Competitive Dashboard
14.2 Global IVD Infectious Disease Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostics
14.3.2 Abbott Laboratories
14.3.3 Abbott
14.3.4 Gen-Probe
14.3.5 Becton Dickinson (BD)
14.3.6 Bio-Rad Laboratories
14.3.7 Siemens Healthcare
14.3.8 Biomérieux
14.3.9 Danaher
14.3.10 Thermo Fisher
14.3.11 Sysmex